Guerbet has appointed two new directors to its executive committee.
Raffi has been named director of commercial operations, and Bernhardt has become director of industrial operations.
Raffi brings more than 20 years of medical technology experience to his new post and has previously served at Allergan and Medtronic. His most recent position was as chief operating officer at Sim&Cure, a company dedicated to the treatment of aneurysms based on AI.
Bernhardt has decades in the pharmaceutical industry, including more than 20 years with companies such as Merck/Millipore and Alphatecspine, Guerbet said.
